Abstract
Once onset of clinical rabies develops in an individual, death is inevitable. Thus, it is imperative that, for persons exposed or potentially exposed to rabies virus, prophylaxis must be instituted as soon as possible following the exposure.
Local wound management is an essential part of postexposure rabies prophylaxis. Exposed persons should receive a recommended series of a tissue culture or cell culture origin vaccine. The number of doses and route of vaccination differ in various regions of the world and are discussed in the text. The administration of a rabies immune globulin is generally recommended in conjunction with the first dose of the rabies vaccine. Nerve tissue origin vaccines, although used extensively in some parts of the world, are not recommended if cell or tissue culture vaccines are available. Decision trees are presented in the text to aid in determining if rabies vaccine is necessary following a known or presumed exposure to the virus, along with a table outlining the various rabies vaccines available in the World. Rabies pre-exposure immunisation is recommended for those individuals at risk of exposure to the virus. Pre-exposure prophylaxis consists of 3 doses of an approved rabies vaccine administered either intramuscularly or intradermally on days 0, 7, and 21 or 28 with periodic booster doses or titre determination depending on the level of risk of potential exposure to the virus.
Article PDF
Similar content being viewed by others
References
Baer GM, Lentz TL. Rabies pathogenesis to the central nervous system. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton (FL): CRC Press, 1991: 105–20
World Health Organization. WHO Expert Committee on Rabies, eighth report. WHO Tech Report Series 824. Geneva: WHO, 1992
Centers for Disease Control and Prevention. Rabies prevention— United States 1991: recommendations of the Immunization Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 40 (no. RR-3), 1991
Dreesen DW. Aglobal review of rabies vaccines for human use. Vaccine 1997; 15 Suppl.: S2–6
Wilde H. Rabies, 1996. Int J Infect Dis 1997; 1: 135–42
World Health Organization. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO/EMC/ZOO 96.6. Geneva: WHO, 1996
World Health Organization. Report of a WHO consultation on intradermal application of human rabies vaccines. WHO/ Rab/95.47. Geneva: WHO, 1995
Cabasso VJ. Local wound treatment and passive immunization. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton (FL): CRC Press, 1991: 551–70
Centers for Disease Control and Prevention. Rabies prevention— United States, 1998. Recommendations of the Advisory Council on Immunization Practices (ACIP). Centers for Disease Control and Prevention: Atlanta (GA). In press
Centers for Disease Control and Prevention. Human rabies —Texas and New Jersey, 1997. MMWR Morb Mortal Wkly Rep 47: 1–5, 1998
World Health Organization. World survey for rabies 1992. Report no. 94.210. Geneva: WHO, 1994
Vodopija I, Clark HE Human vaccination against rabies. In: Baer GM editor. The natural history of rabies. 2nd ed. Boca Raton (FL): CRC Press, 1991: 571–95
Heimick CG, Johnstone C, Winkler WG, et al. A clinical study of Merieux human rabies immune globulin. J Biol Stand 1976; 37: 273–86
Tantawichien T, Benjavongkulchai M, Wilde H, et al. Value of skin testing for predicting reactions to equine rabies immune globulin. Clin Infect Dis 1995; 21: 660–2
Kosiptrapa C, Limsuwun K, Wilde H, et al. Immune response to simulated postexposure rabies booster vaccination in volunteers who received preexposure vaccinations. Clin Infect Dis 1997; 25: 614–6
Author information
Authors and Affiliations
Corresponding author
Additional information
The opinions expressed in this article are those of the authors and may not represent those of the organisations to which they belong
Rights and permissions
About this article
Cite this article
Dreesen, D.W., Hanlon, C.A. Current Recommendations for the Prophylaxis and Treatment of Rabies. Drugs 56, 801–809 (1998). https://doi.org/10.2165/00003495-199856050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199856050-00005